Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

T-STAT

ERYTHROMYCIN

Standard Dose
2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview T-STAT is listed in Drugs@FDA under application 062436 (ANDA).

Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength SOLUTION;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor WESTWOOD SQUIBB Submission history Latest submission status date: 1983-03-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview T-STAT is listed in Drugs@FDA under application 062436 (ANDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength SOLUTION;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor WESTWOOD SQUIBB Submission history Latest submission status date: 1983-03-09 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.